Your browser doesn't support javascript.
loading
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
Stefanescu Schmidt, Ada C; Kereiakes, Dean J; Cutlip, Donald E; Yeh, Robert W; D'Agostino, Ralph B; Massaro, Joseph M; Hsieh, Wen-Hua; Mauri, Laura.
Affiliation
  • Stefanescu Schmidt AC; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Kereiakes DJ; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Cutlip DE; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Yeh RW; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • D'Agostino RB; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Massaro JM; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Hsieh WH; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
  • Mauri L; From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and V
Circulation ; 135(18): 1720-1732, 2017 May 02.
Article in En | MEDLINE | ID: mdl-28228427

Full text: 1 Database: MEDLINE Main subject: Coronary Thrombosis / Ticlopidine / Platelet Aggregation Inhibitors / Aspirin / Acute Coronary Syndrome / Angina, Stable / Percutaneous Coronary Intervention / Prasugrel Hydrochloride / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Circulation Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Coronary Thrombosis / Ticlopidine / Platelet Aggregation Inhibitors / Aspirin / Acute Coronary Syndrome / Angina, Stable / Percutaneous Coronary Intervention / Prasugrel Hydrochloride / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Circulation Year: 2017 Type: Article